OFM
Omega Fund Management Portfolio holdings
AUM
$154M
1-Year Est. Return
32.78%
1 Year Est. Return
-32.78%
AUM
$169M
AUM Growth
+$15.3M
(+9.9%)
Holding
14
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KMTS
1
Kestra Medical Technologies
KMTS
$1.39B
| $44.8M | 26.41% |
+1,795,893
|
|
||
|
BCAX
2
Bicara Therapeutics
BCAX
$928M
| $28.7M | 16.95% |
2,204,650
|
|
||
|
BBNX
3
Beta Bionics
BBNX
$1.03B
| $24.3M | 14.36% |
+1,988,287
|
|
||
4
Nuvation Bio
NUVB
$1.73B
| $23M | 13.58% |
13,072,340
|
|
||
5
Replimune Group
REPL
$728M
| $19.3M | 11.36% |
1,975,203
|
|
||
|
UPB
6
Upstream Bio Inc
UPB
$1.27B
| $12.5M | 7.35% |
2,036,293
|
|
||
7
Lexeo Therapeutics
LXEO
$708M
| $4.11M | 2.43% |
1,184,636
|
|
||
|
ALMS
8
Alumis Inc
ALMS
$501M
| $4.01M | 2.37% |
653,223
|
|
||
|
IMA
9
ImageneBio Inc
IMA
$93.4M
| $2.88M | 1.7% |
187,427
|
|
||
10
enGene Holdings
ENGN
$407M
| $2.36M | 1.39% |
526,357
|
|
||
11
Immunic
IMUX
$82.4M
| $1.95M | 1.15% |
1,788,160
|
|
||
12
Sana Biotechnology
SANA
$1.35B
| $1.42M | 0.84% |
843,750
|
|
||
|
13
enGene Holdings Warrants
ENGNW
$24.6M
| $193K | 0.11% |
321,502
|
|
||
|
SYRS
14
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| – | – |
-251,270
|
|